MeSH D011248 - pregnancy complications
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005261:Female urogenital diseases and pregnancy complications
0 Companies
0 Drugs
Success rate
D011248:
Pregnancy complications
0 Companies
0 Drugs
Success rate
D000022:Spontaneous abortion
0 Companies
0 Drugs
Success rate
D000033:Threatened abortion
0 Companies
0 Drugs
Success rate
D000079262:Maternal obesity
0 Companies
0 Drugs
Success rate
D005313:Fetal death
D005315:Fetal diseases
0 Companies
0 Drugs
Success rate
D006559:Pemphigoid gestationis
0 Companies
0 Drugs
Success rate
D006831:Polyhydramnios
0 Companies
0 Drugs
Success rate
D007744:Obstetric labor complications
0 Companies
0 Drugs
Success rate
D010922:Placenta diseases
0 Companies
0 Drugs
Success rate
D011249:Cardiovascular pregnancy complications
0 Companies
0 Drugs
Success rate
D011250:Hematologic pregnancy complications
0 Companies
0 Drugs
Success rate
D011251:Infectious pregnancy complications
D011252:Neoplastic pregnancy complications
0 Companies
0 Drugs
Success rate
D011254:Pregnancy in diabetics
0 Companies
0 Drugs
Success rate
D011271:Ectopic pregnancy
D011273:Prolonged pregnancy
0 Companies
0 Drugs
Success rate
D011644:Puerperal disorders
0 Companies
0 Drugs
Success rate
D016104:Oligohydramnios
0 Companies
0 Drugs
Success rate
D016640:Gestational diabetes
0 Companies
0 Drugs
Success rate
D017042:Maternal phenylketonuria
0 Companies
0 Drugs
Success rate
D020150:Chorea gravidarum
0 Companies
0 Drugs
Success rate
D046110:Pregnancy-induced hypertension
0 Companies
0 Drugs
Success rate
D048968:Morning sickness
0 Companies
0 Drugs
Success rate
D049188:Prenatal injuries
0 Companies
0 Drugs
Success rate
D053589:Nuchal cord
0 Companies
0 Drugs
Success rate
D059952:Pelvic floor disorders
0 Companies
0 Drugs
Success rate
D063130:Maternal death
0 Companies
0 Drugs
Success rate
D066087:Perinatal death
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
67%6/9
Phase 3
9%2/23
Approved: 0Overall Success rate: 6%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use